Objective: Point-of-care testing (POCT) is a commonly used technology that hastens the time to laboratory results in emergency departments (ED). We evaluated an ED-based POCT program on ED length of stay (LOS) and time to care, coupled with qualitative interviews of local ED stakeholders.
P oint-of-care testing (POCT)-or testing administered outside of a central laboratory-is a commonly used technology in hospital-based and freestanding emergency departments (EDs). Advantages of ED POCT include portability and allowing for providers to rapidly obtain and act upon test results. The goal is to reduce time to diagnosis and initiation of treatment and improve ED efficiency. Several studies have assessed turnaround times for test results comparing POCT to central laboratory testing and have demonstrated that POCT is considerably faster than the central laboratory. [1] [2] [3] However, how POCT impacts specific care in ED varies based on clinical context. Specifically, studies have shown variable impact of POCT on ED length of stay (LOS), time to detection of critical illness (i.e., acute myocardial infarction or sepsis), and time to specific interventions. [4] [5] [6] Timely care is particularly important in the context of worldwide ED crowding, with clear links between delays in care, boarding, and higher mortality rates. [7] [8] [9] [10] [11] The variable impact of POCT on ED efficiency and outcomes is likely driven by several factors, including the ED environment itself, how POCT is implemented and used by the providers, and how POC results translate to more rapid patient care. 12, 13 To our knowledge, no studies have used a mixed-methods approach to examine the impact of POCT on time to care and ED care, specifically with quantitative and qualitative methods to explore attitudes on how POCT is used in practice and how that translates to the observed impact of POCT on ED process and efficiency.
In this study, we evaluated an ED-based POCT program. The primary outcome of our study was the time of patient arrival to time of test result. We also examined the impact on overall ED LOS and coupled the quantitative analysis with qualitative interviews of local stakeholders in the ED.
METHODS

Study Design and Setting
We conducted a mixed-methods before-after study to examine the impact of POCT in a single, community ED (Touro Infirmary) with 30,000 annual ED visits. Our goal was to examine how the implementation of ED POCT impacted time to test laboratory test result and ED patient LOS, utilization of ED-based laboratory testing, and how ED staff reported using POCT as well as percieved benefits and challenges to use. The study was approved by the institutional review boards at Touro Infirmary and George Washington University.
Quantitative Methods
We conducted a retrospective observational study on ED arrivals treated at Touro Infirmary main ED from September 1, 2012, to August 31, 2016. Touro Infirmary implemented i-STAT cardiac troponin (cTnI) and i-STAT Chem8+ (Abbott Point of Care) on September 16, 2014. After POCT implementation, physicians were permitted to order i-STAT cTnI or i-STAT Chem8+ on patients who were in the ED. i-STAT cTnI measures blood cTnI levels in 10 minutes while i-STAT Chem8+ measures nine chemistries/electrolytes (sodium, potassium, chloride, total carbon dioxide, anion gap, ionized calcium, glucose, urea nitrogen/ urea, creatinine), hematocrit, and hemoglobin levels in 2 minutes, according to the manufacturer.
The study team developed a data dictionary defining all clinical, demographic, and time-stamped data for the study. The study investigators worked closely with hospital information technology staff to collect the requested data elements for all ED visits during the study period. For each ED visit, we obtained data on patient demographics (age, sex, race), mode of arrival (ambulance or walk-in), chief complaint, arrival and discharge times, and disposition (admitted, discharged, transferred). A second data set was obtained from a third-party vendor that collects central laboratory, radiology, and POCT data for the hospital. This data set contined all radiology tests ordered, labs ordered (central laboratory and POC tests), and result times. The two data sets were then merged using a unique patient-visit identification.
Patients of all ages were included in the study sample; however, most patients treated in the main ED were adults as children are typically are treated at the nearby Children's Hospital, which was not included in our sample. Upon arrival, a triage nurse evaluated the patient using a five-level emergency severity index (ESI) triage, where 1 = immediate care, 2 = high-risk, multiple-resources needed, 3 = multiple resources needed, 4 = a single resource needed, and 5 = no resources needed. 14 We excluded patients triaged at Level 5 as these patients would not typically receive laboratory tests (n = 1,074). We also excluded patients who died before discharge (n = 61) or left without being seen/left against medical advice (n = 1,249).
Several logic checks were performed to identify and remove data entry errors and outliers. First, laboratory orders with an arrival to result time less than zero or greater than the overall LOS were removed. Next, laboratory outliers were identified as any laboratory orders with an arrival to result time greater than four interquartiles above the 75th percentile or four interquartiles below the 25th percentile, calculated seperately for each type of laboratory order (central laboratory troponin, central laboratory chemistry, central laboratory others, POC troponin, and POC chemistry). Outliers for overall LOS were identified and ACADEMIC EMERGENCY MEDICINE • October 2018, Vol. 25, No. 10 • www.aemj.org removed in the same manner. Finally, a small number (n = 14) of duplicate visit entries were identified and removed.
Central laboratory troponin and chemistry orders were identified by text searching the order names for "troponin" and "metabolic." Both comprehensive and basic metabolic panels were included. Dummy variables were coded for chief compaints that most frequently received a troponin or a chemistry lab (chest pain, abdominal pain, shortness of breath, general weakness, and nausea/vomitting). Patients with a chief complaint of asthma or chronic obstructive pulmonary disease were included with shortness of breath. Chief compaints coded as "chest tightness" or "chest pressure" were included with chest pain.
Our primary outcome of interest was duration, measured in minutes, between patient arrival, and first troponin or chemistry test results received. The time stamp for results received was calculated as the result being ready for review. For both POCT and central laboratory tests, once the result is ready for viewing, an icon flashes on the screen to notify providers that results are ready for viewing. For our main analysis we included, seperately, any visits that received a central laboratory troponin or central laboratory chemistry in the preintervention period and any visits that received an POC troponin and POC chemistry in the postintervention period. As a secondary outcome we examined overall LOS for these same patients. We also examined the overall usage of POCT and central laboratory testing throughout the study period.
Data Analysis
Patient demographic and clinical characteristics for visits that received a central laboratory test (troponin or chemistry) in the preintervention period were compared to visits that received a POCT in the postintervention period. To test if the pre-and postintervention groups were statistically different, we used linear and logistic regression with cluster-adjusted standard errors, given that some patients had multiple visits throughout the study period and therefore were not completely independent samples.
To improve the comparability of the pre-and postintervention groups, we used propensity score weighting. Propensity score weighting is a statistical methods intended to make groups more comparable by applying weights to observations in the comparison group (i.e., preintervention) to construct a group more similar to the treatment group for observed covariates. 15 We used the Stata command psmatch2 to calcualte propensity score weights using 1:1 nearest neighbor matching allowing for ties. 16 We then used these weights to create monthly averages of time from arrival to first troponin result, arrival to first chemistry result, overall LOS for patients with a troponin laboratory value, and overall LOS for patients with a chemistry laboratory value.
To estimate the effect of POCT implementation on our outcomes of interest we used an interrupted time series analysis (ITSA). ITSA is a useful too in health care quality improvement when a randomized trial is not feasible. 17 ITSA is preferable to simple beforeafter analysis because of its ability to control for secular preexisitng trends in the outcomes of interest prior to implementation. We aggregated ED visits into monthly averages, creating 24 time periods in the preintervention period and 23 in the postintervention period. POCT was implemented in the middle of September 2014 so we excluded this month from the ITSA. We used ordinary least squares regression on both a propensity score-weighted and an unweighted sample to measure the change in level and slope in the postintervention period compared to the preintervention period. Based on prior literature with POCT implementations in other settings, we hypothesized that POCT would reduce the average time from arrival to first troponin or chemistry result. However, because most patients still received central laboratory orders in addition to POCT, we did not believe that there would be an effect on patient's overall LOS. The institutional review board at Touro Infirmary approved this study. A two-tailed p-value of <0.05 was used to assess statistical significance. Stata version 15.1 was used for all analysis.
Qualitative Methods
For the qualitative study we completed a total of five semistructured qualitative interviews, which were conducted in 2016 with three ED physicians including the physician director, a nurse practitioner, and an ED nurse who were all working in the ED throughout the implementation of POCT. The goal was to evaluate the effects of POCT on patient care and outcomes as well as to identify challenges to using POCT in the ED. The topics included in interview questions focused on clinician utilization of POCT in the ED, the impact of POCT on metrics such as waiting times and LOS, and the impact of POCT on specific patient populations. The semistructured interview guide was developed and then revised and improved upon by the research team after completion of the initial set of interviews. All interviews were tape-recorded and transcribed. Identification of themes was done in an iterative process based on grounded theory. 18 Coders reviewed transcripts to identify initial codes. Codes took the form of short descriptive phrases generated from transcription review. Codes were used to organize and review the data and emergent themes were developed. The research team then met to discuss and alter these codes to develop the final codebook. Three researchers individually coded each transcript and then discussed and resolved differences in the codes and themes.
RESULTS
Quantitative Results
A total of 47,560 ED visits were included in the study after exclusions (24, 778 in the preintervention period and 22,781 in the postintervention period). After POCT was implemented in September 2014, the proportion of visits with any laboratory ordered (central laboratory and POC) slightly increased from 61% of visits in the preintervention period to 62% of visits in the postintervention period (p = 0.094; Figure 1 ). There were also no significant changes in the proportion of patients that received any chemistry or any troponin. However, the proportion of visits with central laboratory chemistries and central laboratory troponins did decline significantly ( Figure 2 ). Central laboratory chemistries declined from being used in 52% of visits in preintervention period to 21% after intervention (p < 0.001). Central laboratory troponins declined from 24% of visits to 7% (p < 0.001). After implementation, POC troponin was used in 20% of visits and POC chemistry in 34%.
Characteristics of patients that received a central laboratory chemistries or troponins in the preintervention period were compared to patients that received POCT in the postintervention period (Table 1) . Relatively small but statistically significant differences were found in a number of categories. For example, a larger proportion of patients were triaged as Level 3 (and fewer as Level 2) for both POC troponin POC chemistry and patients that received POCT were more often admitted to the intensive care unit or telemetry than patients who received a central laboratory test. Patients who received a POC chemistry were older, on average, than patients who received a central laboratory chemistry. The propensity score weighting created balanced samples on observable patient characteristics in the pre-and postintervention periods. The propensity score weights were then used to create monthly averages for arrival to result time and overall LOS. Patient characteristics after propensity score weighting are available in the Data Supplement S1 (available as supporting information in the online version of this paper, which is available at http://onlinelibrary.wiley.c om/doi/10.1111/acem.13450/full). Table 2 present findings from the ITSA analysis for time to results. Visual inspection of troponins (Figure 3) and chemistries ( Figure 4) showed a declining trend prior to the intervention and a significant drop from about 90 minutes to 66 minutes (a 27% decline) for troponins and 89 minutes to 63 minutes (a 29% decline) for chemistries immediately following implementation of POCT. The declining trend continued in the postintervention period, but at a slower rate. The propensity score weighted models estimate a 21.1 minutes (95% CI = -28.3 to -13.9) decline in arrival to first troponin result and a 22.6 minute (95% CI = -31.5 to -13.7) decline for arrival to first chemistry result immediately following POCT implementation. Similar results were found in the unweighted models. Table 3 presents ITSA findings for LOS, which revealed no statistically significant effect for either troponins or chemistries. Figures 5and 6 visually depict the trend in overall LOS before and after implementation of POCT. For both troponins and chemistries, there was no visual indication that a change in either trend or level occurred after implementation of POCT.
Qualitative Results
Five interviews were conducted with various members of the ED care team including one nurse with 10 years of experience, one nurse practitioner with 16 years of experience, and three physicians, one of whom was the medical director. The physicians had been working at this ED for 3 to 5 years. The majority of comments (59%) were related to the benefits of POCT in improving the quality of care. Just over onethird of comments (38%) discussed some of the p-value calculated using cluster robust standard errors, to account for multiple visits by the same period over the study period. *p < 0.05, **p < 0.01, ***p < 0.001. ICU = intensive care unit; Med/Surg = medical & surgical; OB = obstetrics & gynecology; POCT = point-of-care testing.
barriers and challenges of POCT. Relatively few comments (4%) discussed potential expansion of POCT. Nearly two-thirds (64%) of the comments related to quality had to do with direct improvements in patient care (Table 4) . Providers discussed several specific clinical scenarios where they felt that POCT was valuable. The most common situation mentioned by ED providers was an improvement in care for patients in need of an urgent computed tomography (CT) scan with intravenous (IV) contrast where a POC creatinine can hasten the ability to obtain CTs. Nearly all providers also mentioned improvements in care for patients with potential cardiac symptoms as well as for patients with potentially abnormal electrolytes, especially patients on hemodialysis with end-stage renal disease where hyperkalemia is a concern. All of the providers perceived that POCT led to reduction in the amount of time to complete a medical evaluation, resulting in reduced time for test results as well as faster disposition. Finally, providers felt that POCT seemed to improve patient satisfaction and helped to reduce patient anxiety about dangerous medical conditions due to more rapid test results.
?>Emergency department providers did report some challenges with POCT. Approximately onethird of the comments (32%) related to concerns about POCT accuracy. This most often reflected one of two specific concerns: the first was Intercept, level, and trend data presented in minutes. For visits where a patient had multiple troponins or multiple chemistries ordered, only the first returned order is included. Chemistries includes basic and comprehensive orders. Postintervention period only includes POCT orders. Weighted model uses nearest-neighbor propensity score matching to balance covariates between preintervention and postintervention observations. *p < 0.05, **p < 0.01, ***p < 0.001. POCT = point-of-care testing. concerning falsely elevated potassium in the setting of hemolyzed specimens, which were not shown on the POC machine. The second concern was values that were elevated beyond the capacity of the machine, for example, extreme hyperglycemia. This led to concerns about the reliability of POCT compared to central laboratory values. Another major challenge in POCT was technical in nature. After the results were obtained on the POC handheld device, the nursing staff was dependent on the local Internet network for transmission of results to the computer. However, when there were issues with the wireless network there might be a delay in appearance of the results in the computer. However, this obstacle could be overcome by manually showing results from the machine to the provider or printing out a paper copy of results. When POC testing was first introduced, providers noted some challenges around adoption by all ED providers. While many of the challenges improved with time, there were a few other challenges that were discussed by the ED providers that affected local implementation of POC testing. There were some restrictions on the tests that were available for use to the ED providers; for example, the hemoglobin and hematocrit values were initially hidden on all results. There were other local practice patterns that did not strictly follow the manufacturer guidelines for the use of POCT. Specifically, the POC troponin is meant to be available for a delta-troponin measurement in the Intercept, level, and trend data presented in minutes. Chemistries includes basic and comprehensive orders. Postintervention period only includes patients with at least one POCT ordered. Weighted model uses nearest-neighbor propensity score matching to balance covariates between preintervention and postintervention observations. * p < 0.05, **p < 0.01, ***p < 0.001. LOS = length of stay; POCT = point-of-care testing ED; however, local practice is to admit patients to the hospital who need serial troponin measurements. The inpatient teams exclusively use troponins from the central laboratory so the delta-troponin is not often obtained with POCT. Finally, there was some concern raised about potential overutilization of laboratory services when POC results were repeated in the laboratory; however, this was an uncommon concern.
DISCUSSION
In a single, community ED, POCT was integrated rapidly into ED care, where POC troponins and POC chemistries (in the first 3 months), replaced central laboratory testing for the same indications with no little overall impact on the use of laboratory testing. Patients receiving troponin and chemistry 119 (64%) "In the past before we had the POC for the chemistry it would take like so long for us to get the chemistry back especially if we needed it for a CT with IV contrast, we need the BUN and creatinine and it was taking-delaying us like 45 minutes to an hour. Now we get it back within five minutes at the most and we would have that test back and we send them straight to CT." ". . . somebody with chest pain who's not having a STEMI but we're really concerned about ACS or NSTEMI so if the troponin comes back like it should in a few minutes then we can start those patients on heparin or get the cardiologist involved right away rather than waiting an hour for lab results." "Anybody who has abnormal chemistries and something needs to be corrected quickly, so we have a lot of dialysis patients in our hospital . . . So that is one way that it is extremely helpful if we have a patient like that [on HD] and we can get the potassium level back within a few minutes to know whether we need to start treating for hyperkalemia."
Reduction in time to evaluation or test results
(24%)
"So, we feel that patient quality and efficiency improves and we're going to get you the answer faster and improve our length of stay." "I think it's a great benefit for the ED, because it just enhances your ability to move forward with the next step in your patient care, whether to admit the patient or discharge the patient. You have that ability to read those results and apply it to your next step."
More rapid treatment of dangerous conditions
(7%)
"I think your sickest patients are the ones that could benefit from the quickest active management." "It happens every week that I get a measurement that I wasn't expecting that causes us to take an actionable change faster, so I think that it absolutely improves care and quality and patient experience." Improvement in patient well-being or satisfaction 9 (5%) "I think it's a great benefit it enhances our quality of care where we are able to reduce our wait times so we reduce patient anxiety from patient's waiting so long in the waiting room or in a bed."
Challenges of POCT
Point-of-care test accuracy 35 (32%) "You know you can't read hemolysis on the i-STAT so you come back with a potassium strangely elevated, in somebody that you're kind of wondering about. So I have to draw a regular lab and it will be completely normal." "If something on the POC either seems incorrect and we want to verify it with the lab, or sometimes our POC machine-if the values are far out of the range of normal then the machine will not look for the value at all. So say that someone's potassium was an 8 or a 9, then the machine would not even report it. So to get a value we would have to send it to the lab."
Technical barriers to POCT 32 (29%) "We still have issues to work out, our i-STAT machines are wireless and sometimes they don't update to the computer system and sometimes we see some delays there." ". . . We put the labs in and move on and see another patient while we're waiting and the rest of the labs are coming back from the lab and we realize that the chemistry or the troponin never crossed over and then the nurse has to go back to the machine and manually make it transmit." After POCT implementation, ED LOS continued to decline for patients who received POCT. However, attributing further declines solely to POCT implementation was not possible. From these results, there are several inferences can be made that expand the literature on what is known about POCT in the ED. The first and most important is effective use of POCT-as was implemented in this hospital-should allow POCT to replace central laboratory testing, rather than ordering both central laboratory and POC tests. ED visits that received central laboratory test for troponins declined from 24% to 7% and from 52% to 21% for chemistries in the preinterention period versus postintervention. Interestingly, there was a concern by staff POCT would increase overall laboratory testing, which increased from 61% to 62%. To our knowledge, no prior studies have directly measured whether the addition of POCT replaces or adds to the volume of laboratory testing. Yet, for some patients, particularly specific scenarios where the precise result is important-such as in the case of hemodialysis patients-there are limitations to POC testing, which was also elicited from interviews, particularly because of the inability of POCT to distinguish hemolysis and know definitively whether elevated potassium results represent a true-or false-positive test. This is an important limitation of POCT that should be considered when interpreting results and selecting patients for testing. Specifically providers should consider repeating some tests, particularly when they are positive or grossly abnormal or do not fit within the clinical picture of a case. While there are some limitations to POCT that make this a POC-specific issue (i.e., the inability to detect hemolysis), it is also in general good clinical practice to repeat abnormal laboratory tests where there is a suspicion of false-positive result, even when tests are conducted in the central laboratory.
The areas that POCT was found to be most useful were in cases where early test results may hasten a patient's care for specific conditions, including cases of suspected acute coronary syndrome or electrolyte disturbances or for a creatinine value before receiving a CT scan with IV contrast for time-sensitive conditions such as acute stroke. [19] [20] [21] Faster laboratory results were very important to the interview respondents when it came to improving quality of care, in particular being able to act on a positive or negative test result earlier in the care process. Prior studies have documented that for many indications, including at triage and in the ED that POCT offers more rapid results by the nature of it being a bedside technology, compared to the central laboratory which is often physically remote from the ED where additional time is required to transport specimens and run them on machines that take longer to result. 22, 23 There were also perceptions by the staff that faster test results led to faster dispositions, i.e., reduced LOS. Prior studies have demonstrated shorter lengths of stay and times to disposition when patients receive POC testing, particularly when laboratory testing is the capacity constraint. 24 However, reducing LOS is multifactorial and while reducing time to test result can eliminate some delays in disposition and/or departure, many factors outside of laboratory testing also contribute to longer LOS. 25 In addition, the results of our study did not show a significant reduction in LOS, primarily because of broader quality improvement efforts within the ED that had been implemented prior to POCT had already shortened LOS considerably over the previous 2 years. From this we conclude that POC testing in this setting may have been a useful adjunct to improve ED efficiency in the context of other activities, but itself was not solely responsible for observed improvements in efficiency.
LIMITATIONS
There are several limitations to this study. The first is generalizability, as this is the experience of a single, community ED. The impact of POCT by definition will vary based on the site of implementation and this is no exception. Second, this study only examined a limited range of ED POCT. Other indications such as lactate, D-dimer, and coagulation tests may yield different results.
2 Third, as a before-after study we are limited in the conclusions we can make about the impact of POCT, particularly in the context of other ongoing quality improvement activities or other factors that may have impacted the same outcomes. Importantly, because POCT was part of an ED-wide quality improvement initiative that included several other interventions, the observed impact on LOS was not significant and it was not possible to attribute it solely to POCT.
Ideally, we would have measured other components of the ED visit attributable to POCT, such as time from laboratory order to ED disposition decision or time from laboratory order to result. However, these time stamps were not available in the data set we analyzed. We also did not study other outcomes that may be impacted by POCT including costs, patient experience, or downstream outcomes (i.e., mortality and hospital LOS). Fourth, the control group for chemistries consisted of both comprehensive and basic metabolic panels. The comprehensive metabolic panel includes additional tests that are not included in the Chem8+ (e.g., liver function assessments and albumin) and therefore the Chem8+ is not a direct replacement for a comprehensive panel. Fifth, our primary outcome was calculated using the time of result reported in the patient's record. The result and corresponding time stamp is automatically uploaded to the patient record by the POC blood analyzer. For central laboratories, the result and corresponding time stamp are entered into the patient's record by the laboratory technician. Therefore, our calculation misses any lag between the result time stamp and when a clinician actually saw and acted on the result.
Finally, we only conducted a handful of interviews (five) on the value of POCT. We intentionally interviewed providers that had a rich understanding of the workflow before and after POCT was implemented; however, their experience does not necessarily represent all providers in the ED. While many of the same themes were elicited from all the participants, it is possible that other opinions on POCT may have emerged had we interviewed more or different subjects.
CONCLUSIONS
In this study, the implementation of point-of-care testing at a community hospital was associated with a rapid and sustained replacement of central laboratory testing for troponin and chemistry. Point-of-care testing implementation also reduced the time to troponin and chemistry results, which was felt by staff to have a strong impact on the quality of care delivered. After point-of-care testing implementation, ED length of stay declined for patients who received point-of-care tests; however, the point-of-care testing was implemented in the context of other efforts to improve efficiency; therefore, we could not directly attribute reductions in length of stay solely to point-of-care testing.
